A clinical evaluation of FDG-PET to assess the response in radiation therapy for bronchogenic carcinoma

Annals of Nuclear Medicine

Volumn 10, Issue 2, 1996, Pages 193-200

  Ichiya, Yuichi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

bronchogenic carcinoma; F 18 fluorodeoxyglucose; positron emission tomography; radiation therapy; therapeutic response

Indexed keywords

CARBON 11; FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; FEMALE; HUMAN; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; TREATMENT OUTCOME;

EID: 0030014038     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03165392     Document Type: Article

References (5)

1. Emami B, Ferez CA. Lung. In Principals and Practice of Radiation Oncology, Ferez CA, Brady LAV (eds.), 2nd ed., Philadelphia, pp. 806-836, 1992.
2. Cox JD, Azamia N, Byhardt RW, Shin KH, Emoni B, Pajak TF. A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: Possible survival benefit with > 69.6 Gy in favorable patients with radiation therapy oncology group stage 111 nonsmall cell lung carcinoma: Report of radiation therapy oncology group 83-11. J Clin Oncol 8: 1543-1555, 1990.
3. Kubota K, Matsuzawa T, Fujiwara T, Ito M, Hatazawa J, Ishiwata K, et al. Differential diagnosis of lung tumor with positron emission tomography: A prospective study. J Nucl Med 31: 1927-1933, 1990.
4. Gupta NC, Frank AR, Dewan NA, Redepenning LS, Rothberg ML, Mailliard JA, et al. Solitary pulmonary nodules: Detection of malignancy with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 184: 441-444, 1992.
5. Patz EF Jr, Lowe VL, Hoffman JM, Paine SS, Burrowes S, Coleman RE, et al. Focal pulmonary abnormalities: Evaluation with F-18 fluorodeoxyglucose PET scanning. Radiology 188: 487-490, 1993.